A Phase 2, Double-blind, Placebo-Controlled Study of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients with Metastatic Breast Cancer

Patients with Breast cancer who are receiving chemotherapy will be randomized to receive either ACE-011 or placebo for their anemia.